27.39
price up icon3.51%   0.93
after-market Dopo l'orario di chiusura: 27.39
loading

Perché le azioni Myriad Genetics Inc (MYGN) sono in ribasso?

Abbiamo notato un calo di 5.71% nelle azioni di Myriad Genetics Inc (MYGN) durante la sessione di negoziazione di 2024-09-11. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-09:

Shares of Myriad Genetics (MYGN) dropped by 8.94% from $17.89 to $16.29 in the trading on Thursday, Novemeber 9, 2023. The reason why MYGN down is due to the announcement of an upsized underwritten public offering of 6,470,588 shares of common stock at $17.00 per share, with expected gross proceeds of approximately $110 million. The company intends to use the net proceeds to repay loans, settle litigation, and support working capital and general corporate purposes. The offering is managed by Goldman Sachs & Co. LLC, Morgan Stanley, and Wells Fargo Securities and is subject to customary closing conditions.

diagnostics_research LH
$223.48
price up icon 0.62%
$130.41
price up icon 0.22%
diagnostics_research WAT
$359.89
price up icon 0.72%
$287.31
price up icon 0.60%
diagnostics_research MTD
$1,499.70
price up icon 1.41%
$505.22
price down icon 1.28%
Capitalizzazione:     |  Volume (24 ore):